compound introduction
PF-06282999 是一种有效的，选择性的髓过氧物酶 (myeloperoxidase) 抑制剂，用于心血管疾病的研究。 Information PF-06282999 PF-06282999 is an orally bioavailable, irreversible inactivator of myeloperoxidase enzyme and is currently in clinical trials for the potential treatment of cardiovascular diseases. Targets MPO (LPS-stimulated human whole blood) 1.9 μM Product Describtion: PF-06282999 is a potent and selective myeloperoxidase inhibitor which is potential useful for the treatment of cardiovascular diseases.
